These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16292092)

  • 1. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
    Wenger U; Johnsson E; Bergquist H; Nyman J; Ejnell H; Lagergren J; Ruth M; Lundell L
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1369-77. PubMed ID: 16292092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial.
    Bergquist H; Wenger U; Johnsson E; Nyman J; Ejnell H; Hammerlid E; Lundell L; Ruth M
    Dis Esophagus; 2005; 18(3):131-9. PubMed ID: 16045572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
    Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
    Trials; 2014 Oct; 15():402. PubMed ID: 25336193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.
    Polinder S; Homs MY; Siersema PD; Steyerberg EW;
    Br J Cancer; 2004 Jun; 90(11):2067-72. PubMed ID: 15150566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in palliative therapy.
    Siersema PD
    Best Pract Res Clin Gastroenterol; 2006; 20(5):959-78. PubMed ID: 16997172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.
    Nicholson DA; Haycox A; Kay CL; Rate A; Attwood S; Bancewicz J
    Clin Radiol; 1999 Apr; 54(4):212-5. PubMed ID: 10210338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.
    Touchefeu Y; Archambeaud I; Landi B; Lièvre A; Lepère C; Rougier P; Mitry E
    Dig Liver Dis; 2014 Mar; 46(3):283-6. PubMed ID: 24268567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma.
    Sabharwal T; Hamady MS; Chui S; Atkinson S; Mason R; Adam A
    Gut; 2003 Jul; 52(7):922-6. PubMed ID: 12801944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative therapy.
    Homs MY; Kuipers EJ; Siersema PD
    J Surg Oncol; 2005 Dec; 92(3):246-56. PubMed ID: 16299791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
    Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
    Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
    Bjerring OS; Pless T; Fristrup C; Mortensen MB
    Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
    Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
    Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative treatment of oesophageal carcinoma--efficacy of plastic versus self-expandable stents.
    Sanyika C; Corr P; Haffejee A
    S Afr Med J; 1999 Jun; 89(6):640-3. PubMed ID: 10443214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
    Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
    Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of esophageal stenting for management of malignant dysphagia.
    Rao C; Haycock A; Zacharakis E; Krasopoulos G; Yakoub D; Protopapas A; Darzi A; Hanna GB; Athanasiou T
    Dis Esophagus; 2009; 22(4):337-47. PubMed ID: 19207559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection.
    Steyerberg EW; Homs MY; Stokvis A; Essink-Bot ML; Siersema PD;
    Gastrointest Endosc; 2005 Sep; 62(3):333-40. PubMed ID: 16111947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis.
    Sihvo EI; Pentikäinen T; Luostarinen ME; Rämö OJ; Salo JA
    Eur J Surg Oncol; 2002 Nov; 28(7):711-5. PubMed ID: 12431467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.